Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis

BACKGROUND/AIMS: Sorafenib is the first approved systemic treatment for advanced hepatocellular carcinoma (HCC). However, its clinical utility is limited, especially in Asian countries. Several reports have suggested the survival benefits of hepatic arterial infusion chemotherapy (HAIC) for advanced...

全面介紹

Na minha lista:
書目詳細資料
發表在:Gut Liver
Main Authors: Ahn, Young Eun, Suh, Sang Jun, Yim, Hyung Joon, Seo, Yeon Seok, Yoon, Eileen L., Kim, Tae Hyung, Lee, Young Sun, Yim, Sun Young, Kim, Hae Rim, Kang, Seong Hee, Jung, Young Kul, Kim, Ji Hoon, Yeon, Jong Eun, Um, Soon Ho, Byun, Kwan Soo
格式: Artigo
語言:Inglês
出版: Editorial Office of Gut and Liver 2021
主題:
Original Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7960975/
https://ncbi.nlm.nih.gov/pubmed/32307975
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5009/gnl19367
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍